Dr. Mattar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
818 N Emporia St
Suite 403
Wichita, KS 67214Phone+1 316-262-4467Fax+1 316-262-0706
Summary
- Dr. Bassam Mattar is an oncologist in Wichita, KS and is affiliated with multiple hospitals in the area, including Wesley Healthcare Center, Robert J. Dole Veterans Affairs Medical Center, Newton Medical Center, Ascension Via Christi St. Francis, and Kingman Community Hospital. He received his medical degree from St Joseph's University Medical School and has been in practice 24 years. He also speaks multiple languages, including French and Arabic. He specializes in hematologic oncology and is experienced in hematologic oncology.
Education & Training
University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 1996 - 1999
University of Kansas School of MedicineResidency, Internal Medicine, 1994 - 1996
Montefiore Medical Center/Albert Einstein College of Medicine (Wakefield Campus)Internship, Internal Medicine, 1993 - 1994
St Joseph's University Medical SchoolClass of 1993
Certifications & Licensure
KS State Medical License 1998 - 2025
AL State Medical License 1996 - 1999
IA State Medical License 1994 - 1999- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- American Society of Bone Marrow TransplantationMember
Publications & Presentations
PubMed
- OUTREACH: Phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL.Yuliya Linhares, Cesar O Freytes, Mohamad Cherry, Carlos Bachier, Michael B Maris
Blood Advances. 2024-09-30 - 49 citationsSystemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance)Debra L. Barton, Lynne T. Shuster, Travis J. Dockter, Pamela J. Atherton, Jacqueline M. Thielen
Supportive Care in Cancer. 2018-04-01 - 139 citationsA placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).Aminah Jatoi, Howard L. Ritter, Amylou C. Dueck, Phuong L. Nguyen, Daniel A. Nikcevich
Lung Cancer. 2010-05-01
Professional Memberships
- Member
- Member
Other Languages
- French, Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
